Related Experiment Video
Updated: Apr 22, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
[Adverse systemic reactions in intensive care medicine after isolated limb perfusion with melphalan and hyperthermia:
Fernando Oetterer Arruda1, Hélio Penna Guimarães2, Luiz Fernando Dos Reis Falcão1
1EPM, UNIFESP.
Background And Objectives:
The presence of adverse reactions, inherent to all treatments, justifies the necessity of deep knowledge, by the medical team of the prevention and treatment of occasional organic dysfunctions, reducing its impact. The purpose of this paper is to report a case comprising the several systemic adverse reactions after perfusion of limb with melphalan and hyperthermia.
Case Report:
A white female, 64-years old patient with diagnosis of melanoma in the medial malleoli region of the left lower limb. Six months after surgical removal of wound, an isolated perfusion of limb was carried out with melphalan and hyperthermia in order to curb the possible metastatic process in evolution. At admission in the ICU, the patient presented systemic inflammatory response syndrome (SIRS) with refractary hemodynamic instability to volemic expansion. During internation the patient evolved to acute lung edema and myocardial dysfunction, all reverted successfully.
Conclusions:
The potential presence of adverse reactions, inherent to all treatments, justify the necessity of knowledge by the intensive care team in the prevention and treatment of occasional organic dysfunctions, reducing the impact of morbidity and mortality.
Related Concept Videos
Increased Body Temperature
Homeostatic Imbalances in Body Temperature
Acute Inflammation II: Local and Systemic Effects
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Hemodialysis II: Procedure and Complications
Hypersensitivity Reactions: Cytolytic Reactions

